SCHEMBL8306869

SCHEMBL8306869

CC(=NO)c1ccc(-c2cccnc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 7/20 0.57
MKNK2 Q9HBH9 7/20 0.57
ALDH1A1 P00352 3/20 0.52
CYP2A6 P11509 4/20 0.52
CYP3A4 P08684 2/20 0.52
CYP1A2 P05177 1/20 0.52
KIF11 P52732 1/20 0.50
CYP11B2 P19099 2/20 0.46
KDM4E B2RXH2 1/20 0.46
LMNA P02545 1/20 0.46
TP53 P04637 1/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
ALOX15 P16050 1/20 0.46
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HSD17B10 Q99714 1/20 0.46
CYP19A1 P11511 2/20 0.44
CYP11B1 P15538 1/20 0.44
CYP2D6 P10635 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3144867 0.80 PKM (0.59) ALDH1A1SMN1; SMN2
SCHEMBL3144873 0.80 PKM (0.59) ALDH1A1SMN1; SMN2
SCHEMBL8308938 0.80 CYP17A1 (0.46) CYP3A4KIF11CYP11B2KDM4ELMNA
SCHEMBL10665182 0.80 PKM (0.59) ALDH1A1SMN1; SMN2
SCHEMBL29509895 0.80 PKM (0.59) ALDH1A1SMN1; SMN2
SCHEMBL4316450 0.79 SMN1; SMN2 (0.56) ALDH1A1CYP1A2KDM4ELMNAMAPT
SCHEMBL3368876 0.79 SMN1; SMN2 (0.56) ALDH1A1CYP1A2KDM4ELMNAMAPT
SCHEMBL13645704 0.79 CA9 (0.47) ALDH1A1CYP3A4CYP1A2KDM4ELMNA
SCHEMBL6949381 0.79 MKNK1 (0.71) MKNK1MKNK2ALDH1A1CYP2A6CYP3A4
Hydrochloric Acid SCHEMBL27641130 0.78 PKM (0.57) ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1056840-C Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2000-09-27 CN disclosed
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
CN-1143639-A Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1997-02-26 CN disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed